MedPath

Myopic and Glaucomatous optic neuropathy changes using swept source OCT

Not Applicable
Conditions
Glaucoma
Registration Number
JPRN-UMIN000024047
Lead Sponsor
Topcon Corporation
Brief Summary

It will be analyzing after add about 130 participants. Number of analyzed participants : 328 Reporting about partial results at academic conference started. Example of secondary analysis results: https://doi.org/10.1016/j.ajo.2023.01.003

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
373
Inclusion Criteria

Not provided

Exclusion Criteria

Normal persons: 1.Family history of glaucoma 2.Subjects unable to tolerate ophthalmic imaging 3.Subject with ocular media not sufficiently clear to obtain acceptable OCT images 4.HFA visual field (24-2 Sita Standard, white on white) result abnormal, defined as GHT 'Outside Normal Limits' and/or PSD < 1%, unless due to an enlarged blind spot. 5.HFA visual field (24-2 Sita Standard, white on white) result unreliable (based on manufacturer's recommendation), defined as fixation losses > 20% or false positives > 15% 6.Presence of any ocular pathology or suggestive pathologic observation 7.Previous cataract surgery or refractive surgery, Pseudophakic or aphakic 8.Narrow angle with Shaffer grade 2 or less 9.History of diabetes, leukemia, dementia or multiple sclerosis (disease that produces defect of retinal nerve) 10.History of whole body dosing of steroid or/and anticancer agent 11.Subjects with hypertension/hypotension Glaucoma patients: 1.Subjects unable to tolerate ophthalmic imaging 2.Subject with ocular media not sufficiently clear to obtain acceptable OCT images 3.HFA visual field (24-2 Sita Standard, white on white) result unreliable, defined as fixation losses > 20% or false positives > 15% 4.Presence of any ocular pathology other than glaucoma, or suggestive pathologic observation 5.Previous ocular surgery or laser treatment 6.History of diabetes, leukemia, dementia or multiple sclerosis (disease that produces defect of retinal nerve) 7.History of whole body dosing of steroid or/and anticancer agent 8.Subjects with hypertension/hypotension 9.Narrow angle with Shaffer grade 2 or less 10.Pseudophakic or aphakic

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath